That’s how many would still be alive in a 24-team College Football Playoff right now. Instead, we’re staring at seven programs that appear safely positioned in the 12-team field — a far narrower group ...

The Carolina Panthers, even without taking a snap, came out victorious in Week 14. While they were on their bye, the Tampa Bay Buccaneers tripped up once again—falling to the New Orleans Saints in a ...

Fifteen seasons ago, the Fantasy Football Trade Chart was created by CBS Sports for the sole purpose of helping you make fair trades in your leagues. But in 2025, the Trade Chart expanded! This year, ...

The Detroit Lions are once again banged up heading into a big showdown with the Dallas Cowboys. In a matchup that carries heavy playoff implications, the Lions are dealing with injury questions ...

The Las Vegas Raiders released their updated unofficial depth chart ahead of the Week 14 matchup against the Denver Broncos. Sunday's game kicks off at 1:05 p.m. PT and will air on CBS. Depth charts ...

The Atlanta Falcons have released a new depth chart ahead of Sunday's game against the Seattle Seahawks. There were a few minor changes this week. Rookie edge rusher Jalon Walker was listed as a ...

Welcome back to our updated Week 13 fantasy football start/sit chart for all player matchups and all games this week. The start/sit chart has been updated for the weekend for players like Omarion ...

The Indianapolis Colts released their unofficial Week 13 depth chart ahead of this week's matchup with the Houston Texans. There has been one change made this week, with wide receiver Ashton Dulin ...

Get access to Brad Slager's "Riffed From the Headlines," a daily VIP feature where he looks to bring accountability to the mainstream media. Use promo code FIGHT to get 60% off your VIP membership! It ...

The Detroit Lions are fighting for their playoff lives heading into the final stretch of the 2025 regular season. Currently a game out of the playoff picture, the Lions' annual Thanksgiving matchup ...

An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema). The findings ...